United States

Benitec Biopharma Ltd (BLT.AX)

BLT.AX on Australia Stock Exchange

7:53pm EST
Change (% chg)

$0.00 (+2.86%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. Its In-house product... (more)
No analyst recommendations are available for .


Beta: 2.23
Market Cap(Mil.): $36.93
Shares Outstanding(Mil.): 205.14
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 197.02 15.79
EPS (TTM): -- -- --
ROI: -- -10.12 12.01
ROE: -- -37.71 15.91

BRIEF-Benitec Biopharma says working with regulators to advance BB-301 into the clinic as quickly as possible

* Benitec Biopharma says its BB-301, represents clinical candidate that it intends to advance into human clinical trials in the second half of 2018‍​

Aug 08 2017

BRIEF-Benitec Biopharma says files for stock shelf offering of upto $20 mln

* Benitec Biopharma says files for stock shelf offering of upto $20 million - sec filing Source text (http://bit.ly/2rIk5RV) Further company coverage:

Jun 01 2017

Earnings vs. Estimates